Principal Investigator
Aaron Wolfson
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20220813
Clinical Trial Summary
Phase 1 Clinical Trial of Lenvatinib, Pembrolizumab and Hypofractionated Pelvic Radiation Therapy for pMMR Recurrent/Unresectable Endometrial Carcinoma
Phase
Phase I
Funding Agency/Sponsor
Institutional
Disease
Gynecologic Cancer
Contact Information
Phone Number
305-243-2647